You could be reading the full-text of this article now if you...

If you have access to this article through your institution,
you can view this article in

Treatment and Survival Outcome for Molecular Breast Cancer Subtypes in Black Women

Ihemelandu, Chukwuemeka U. MD*; Naab, Tammey J. MD†; Mezghebe, Haile M. MD*; Makambi, Kepher H. PhD‡; Siram, Suryanarayana M. MD*; Leffall, LaSalle D. Jr MD*; DeWitty, Robert L. Jr MD*; Frederick, Wayne A. MD*‡

Annals of Surgery:
doi: 10.1097/SLA.0b013e31815d744a
Original Articles
Abstract

Objective: To analyze whether the local-regional surgical treatments (breast-conserving therapy, mastectomy) resulted in different overall survival, distant metastasis-free survival, and locoregional recurrence-free survival rates for the various molecular breast cancer subtypes.

Summary Background Data: Molecular gene expression profiling has been proposed as a new classification and prognostication system for breast cancer. Current recommendation for local-regional treatment of breast cancer is based on traditional clinicopathologic variables.

Methods: Retrospective analysis of 372 breast cancer cases with assessable immunohistochemical data for ER, PR, and Her-2/neu receptor status, diagnosed from 1998 to 2005. Molecular subtypes analyzed were luminal A, luminal B, basal like, and Her-2/neu.

Results: No substantial difference was noted in overall survival, and locoregional recurrence rate between the local-regional treatment modalities as a function of the molecular breast cancer subtypes. The basal cell-like subtype was an independent predictor of a poorer overall survival (hazard ratio [HR] = 2.52, 95% confidence interval [CI] 1.28–4.97, P < 0.01) and a shorter distant metastasis-free survival time (HR = 3.61, 95% CI 1.27–10.2, P < 0.01), and showed a tendency toward statistical significance as an independent predictor of locoregional recurrence (HR = 3.57, 95% CI 0.93–13.6, P = 0.06).

Conclusions: The basal cell-like subtype is associated with a worse prognosis, a higher incidence of distant metastasis, and may be more prone to local recurrence when managed with breast-conserving therapy.

In Brief

Basal cell-like breast cancers have a worse prognosis in black women, and the basal cell-like subtype may have increased local recurrence after breast-conserving therapy.

Author Information

From the Departments of *Surgery and †Pathology, Howard University College of Medicine, Washington, DC; and ‡Howard University Cancer Center, Washington, DC.

Supported in part by a research grant from the Susan G. Komen for the Cure Foundation.

Reprints: Wayne A. Frederick, MD, Department of Surgery, Howard University Hospital, 2041 Georgia Ave., N.W., Washington, DC 20060. E-mail: w_frederick@Howard.edu; melands70@gmail.com

© 2008 Lippincott Williams & Wilkins, Inc.